Bcl-2/NN
protein/NN
inhibits/VBZ
bufalin-induced/JJ
apoptosis/NN
through/IN
inhibition/NN
of/IN
mitogen-activated/JJ
protein/NN
kinase/NN
activation/NN
in/IN
human/JJ
leukemia/NN
U937/NN
cells/NNS
./.

In/IN
a/DT
previous/JJ
study/NN
,/,
we/PRP
demonstrated/VBD
that/IN
bufalin/NN
,/,
which/WDT
is/VBZ
an/DT
active/JJ
principle/NN
of/IN
Chinese/NN
medicine/NN
,/,
chan'su/NN
,/,
caused/VBD
apoptosis/NN
in/IN
human/JJ
leukemia/NN
U937/NN
cells/NNS
by/IN
anomalous/JJ
activation/NN
of/IN
mitogen-activated/JJ
protein/NN
kinase/NN
(/(
MAPK/NN
)/)
via/IN
the/DT
signaling/NN
pathway/NN
of/IN
Ras/NN
,/,
Raf-1/NN
,/,
and/CC
MAPK/NN
kinase-1/NN
./.
=====
Here/RB
,/,
we/PRP
report/VBP
the/DT
effect/NN
of/IN
overexpression/NN
of/IN
bcl-2/NN
in/IN
U937/NN
cells/NNS
on/IN
the/DT
signaling/NN
pathway/NN
of/IN
apoptosis/NN
that/WDT
is/VBZ
induced/VBN
by/IN
bufalin/NN
./.
=====
The/DT
results/NNS
indicated/VBD
that/IN
the/DT
apoptosis/NN
induced/VBN
by/IN
bufalin/NN
in/IN
U937/NN
cells/NNS
was/VBD
significantly/RB
inhibited/VBN
by/IN
overexpression/NN
of/IN
the/DT
Bcl-2/NN
protein/NN
./.
=====
No/DT
significant/JJ
difference/NN
was/VBD
detected/VBN
in/IN
the/DT
activation/NN
of/IN
MAPK/NN
kinase-1/NN
that/WDT
is/VBZ
induced/VBN
by/IN
bufalin/NN
in/IN
wild-type/JJ
or/CC
Bcl-2-overexpressed/JJ
U937/NN
cells/NNS
;/:
however/RB
,/,
the/DT
activation/NN
of/IN
MAPK/NN
by/IN
bufalin/NN
was/VBD
significantly/RB
attenuated/VBN
in/IN
the/DT
cells/NNS
overexpressing/VBG
Bcl-2/NN
./.
=====
Bufalin/NN
treatment/NN
activated/VBD
activator/NN
protein-1/NN
transcriptional/JJ
activity/NN
;/:
however/RB
,/,
this/DT
activation/NN
was/VBD
decreased/VBN
to/TO
40/CD
%/NN
in/IN
bcl-2-overexpressed/JJ
U937/NN
cells/NNS
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
Bcl-2/NN
acts/VBZ
downstream/RB
of/IN
MAPK/NN
kinase-1/NN
but/CC
upstream/RB
of/IN
MAPK/NN
and/CC
suggest/VBP
that/IN
,/,
in/IN
the/DT
signaling/NN
pathway/NN
of/IN
the/DT
apoptotic/JJ
process/NN
induced/VBN
by/IN
bufalin/NN
,/,
the/DT
transcriptional/JJ
activity/NN
of/IN
activator/NN
protein-1/NN
may/MD
be/VB
down-regulated/VBN
through/IN
the/DT
inhibition/NN
of/IN
MAPK/NN
activity/NN
by/IN
Bcl-2/NN
./.